期刊文献+

米力农治疗难治性心力衰竭的疗效和安全性 被引量:7

Efficacy and Safety of Milrinone in Treatment of Refractory Heart Failure
暂未订购
导出
摘要 目的 :观察米力农治疗难治性心力衰竭的疗效及安全性。方法 :难治性心力衰竭 45例 ,以米力农 10mg加入 5 %葡萄糖 2 5 0ml中静滴 6h ,每日 1次 ,共 7d。结果 :米力农的临床总有效率为91.1% ,对左室收缩和舒张功能均有明显改善 ,未见不良反应。结论 :米力农治疗难治性心力衰竭 ,安全有效。 Objective: To observe the efficacy and safety of milrinone in the treatment of refractory heart failure. Methods: 45 patients with refractory heart failure received milrinone infusion 10 mg in 5% glucose 250ml continued for 6 h/d, for 7 days. Results: The total clinical response rate was 91.1%. Milrinone has significantly improved left ventricular systolic and diastolic function. Conclusion: Milrinone is an effective and safe drug, which can improve the left ventricular function in patients with refractory heart failure.
出处 《内科急危重症杂志》 2003年第1期20-21,共2页 Journal of Critical Care In Internal Medicine
关键词 米力农 难治性心力衰竭 左室功能 疗效 Milrinone Refractory heart failure Left ventricular function Therapeutic effect
  • 相关文献

参考文献5

  • 1[1]Homejager P. Pharmacology of bipyridine phosphodiesterase Ⅲ inhibitors. Am Heart J ,1991,121(6 Pt 2):1939.
  • 2[2]Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med, 1991,325(21 ) : 1468.
  • 3[3]Cusick DA, Pfeifer PB, Quigg RJ. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. Am J Cardiol, 1998,82(9): 1060.
  • 4[4]Anderson JL. Hemodynamic and Chinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States. Am Heart J, 1991,121 (6 Pt 2): 1956.
  • 5[5]Hatzacharias A, Makris T, Krespi P, et al. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Am Heart J, 1999,138(2 Pt 1 ) :241.

同被引文献33

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部